About 30,300 results
- AstraZeneca - a global research-based biopharmaceutical company
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. Discover the ground-breaking work ...
9 Feb 2012 by Patent Docs
By Andrew Williams -- On Thursday, the Federal Circuit affirmed the dismissal of a § 271(e)(2) patent infringement action based on method-of-use claims because the ANDA filer was only seeking FDA approval for ...
14 Nov 2013 by McDonnell Boehnen Hulbert & Berghoff LLP
Seeking approval to market generic versions of AstraZeneca's Pulmicort Respules® drug, Appellees Breath Ltd.; Apotex, Inc. and Apotex Corp.; Sandoz, Inc.; and Watson Laboratories, Inc. filed Abbreviated New Drug Applications (ANDAs) with
the FDA. In response to those ANDA filings, AstraZeneca brought suit against the .... Hatch-Waxman Watch: AstraZeneca Pharmaceutical LP v. Intellipharmaceutics Corp. (D.N.J. 2012) · AstraZeneca Pharmaceuticals LP v.
17 Oct 2013 by Joel Brakken
Katie L. Bonds filed a lawsuit Sept. 16 in the Circuit Court of Raleigh County against Astazeneca Pharmaceuticals LP. According to the complaint, Bonds was a pharmaceutical sales representative beginning in February 2011.
6 Apr 2010
Appellant Linda Guinn brought suit against Appellee AstraZeneca. Pharmaceuticals LP (AstraZeneca), claiming her use of the prescription drug. Seroquel caused her to develop diabetes. Prior to trial, AstraZeneca filed a.
3 Apr 2013 by mike
A proposed settlement has been reached with AstraZeneca Pharmaceuticals LP, the maker of NEXIUM, in a class action lawsuit pending in Suffolk County Superior Court in the Commonwealth of Massachusetts. The lawsuit ...
27 Nov 2013 by tp-admin
1Clinical Neuroscience Research Unit, Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA; 2AstraZeneca Pharmaceuticals LP, R&D, Wilmington, DE, USA; 3FORENAP, Rouffach, France ...
25 Apr 2013
Findlaw provides ASTRAZENECA PHARMACEUTICALS LP v. FOOD DRUG ADMINISTRATION, No. 12–5227., April 26, 2013 - US DC Circuit | FindLaw.
26 Apr 2010
WASHINGTON – AstraZeneca LP and AstraZeneca Pharmaceuticals LP will pay $520 million to resolve allegations that AstraZeneca illegally marketed the anti-psychotic drug Seroquel for uses not approved as safe and ...
7 May 2010
Date Filed: 5/6/2010; Plaintiff: Dr. George Pieczenik; Defendant: AstraZeneca Pharmaceuticals LP et al; Cause: 28:1338 Patent Infringement.
1 Dec 2010 by pitlawblog
by: Joseph Carnicella, intellectual property attorney at Picadio Sneath Miller & Norton, P.C. In Teva Pharmaceutical Industries Ltd. v. AstraZeneca Pharmaceuticals LP, et al., No. 08cv4786, 2010 U.S. Dist. LEXIS 112597 (E.D. ...